Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status

Abstract Introduction We evaluated for two novel automated biomarker assays how cerebrospinal fluid (CSF) amyloid beta (Aβ)1– 42‐ratios improved the concordance with amyloid positron emission tomography (PET) positivity compared to Aβ1– 42 alone. Methods We selected 288 individuals from the Amsterda...

Full description

Bibliographic Details
Main Authors: Eline A. J. Willemse, Betty M. Tijms, Bart N. M. vanBerckel, Nathalie Le Bastard, Wiesje M. van derFlier, Philip Scheltens, Charlotte E. Teunissen
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Alzheimer's disease
amyloid‐beta
amyloid positron emission tomography
biomarkers
cerebrospinal fluid
concordance cut‐points
Online Access:https://doi.org/10.1002/dad2.12182

Internet

https://doi.org/10.1002/dad2.12182

Similar Items